Steven D. Harr
Overview
Steven D. Harr received an average of $4M in total compensation, including $597K in salary, at Sana Biotechnology from 2020 to 2022. Steven Harr also received an average of $3M at Juno Therapeutics from 2014 to 2016.
- 2022
- 2021
- 2020
- 2016
- 2015
- 2014
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Juno TherapeuticsChief Financial Officer and Head of Corporate Development
Juno TherapeuticsChief Financial Officer and Head of Corporate Development
Juno TherapeuticsChief Financial Officer and Head of Corporate Development
Source: SEC filings on April 28, 2023, April 26, 2022, and April 21, 2017.
Related executives
We found seven more executives who work or worked at Sana Biotechnology and Juno Therapeutics.
Bernard Cassidy
Sana Biotechnology
General Counsel
Sunil Agarwal
Sana Biotechnology
Chief Medical Officer
Nathan Hardy
Sana Biotechnology
Chief Financial Officer
Hans Bishop
Juno Therapeutics
Chief Executive Officer
Hyam Levitsky
Juno Therapeutics
Chief Scientific Officer
Robert Azelby
Juno Therapeutics
Executive Vice President, Chief Commercial Officer
Mark Frohlich
Juno Therapeutics